
James Blachly
@jamesblachly
Hematologist and Computational Biologist. I am a doctor but I am not your doctor, this is not financial advice, and look both ways before crossing the street.
ID: 24837540
17-03-2009 04:12:20
672 Tweet
708 Followers
438 Following

CONGRESS | #ASH22 James Blachly, Ohio State presented early results from a study of MS-553, a highly selective PKC β inhibitor. Enrolled pts had #CLL or #SLL and were heavily pretreated. MTD was not reached. 48% of pts achieved PR/PRL with MS-553 monotherapy. #lymsm #hematology




Brian Shaffer Krishna Komanduri, MD, FASTCT ASH MEASURE data is coming - I heard Brian Shaffer MSKCC Lori Muffly Stanford University Elizabeth Krakow Fred Hutch Cancer Center Dr Salhotra and Amanda Blackmon City of Hope Chris Gibson Dana-Farber Alexandra Gomez A. Weill Cornell Leukemia James Blachly Ohio State Antonio Jimenez Jimenez UMiami Health System and other leaders are on the case!





GREAT WORK on folate role in hematopoietic development by briankrum1 presented as #ASH23 plenary scientific. 🙌🏻 I loved the first question which was a practical one: should we have BMT recipients supplement folate?


Menin inhibition will dramatically change the treatment of acute leukemia. We get first taste of this with KMT2A-r data on revumenib at #ASH23 LBA-5 ; can't wait for data on more drugs, new contexts, and combos 🚀 Great job Ibrahim Aldoss City of Hope !






What an absolutely outstanding meeting thus far! I am blown away. Can’t wait for the next sessions—thank you #DAVAOnc MD Anderson Cancer Center Tapan Kadia James Blachly John F. DiPersio Lab

